New drug DT402 aims to ease social struggles in adults with autism
Symptom relief
Recruiting now
This study tests an experimental drug called DT402 in 20 adults aged 18 to 65 with autism spectrum disorder. The goal is to see if it can reduce the severity of social and communication difficulties. Participants take the drug and report their experiences using simple rating scal…
Phase: PHASE2 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated May 17, 2026 13:58 UTC